A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
NCT02174835
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AVP-786
DRUG:
AVP-923
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.